In Vitro Activity of the Echinocandin Antifungal Agent Ly303,366 in Comparison with Itraconazole and Amphotericin B against Aspergillus spp
Oakley, K.L.; Moore, C.B.; Denning, D.W.
Antimicrobial Agents and Chemotherapy 42(10): 2726-2730
1998
ISSN/ISBN: 0066-4804
DOI: 10.1128/aac.42.10.2726
Accession: 067646265
PDF emailed within 0-6 h: $19.90
Related References
Oakley, K.L.; Moore, C.B.; Denning, D.W. 1998: In vitro activity of the echinocandin antifungal agent LY303,366 in comparison with itraconazole and amphotericin B against Aspergillus spp Antimicrobial Agents and ChemoTherapy 42(10): 2726-2730Carrillo-Muñoz, A.J.; Quindós, G.; Tur, C.; Ruesga, M.T.; Miranda, Y.; del Valle, O.; Cossum, P.A.; Wallace, T.L. 1999: In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole Journal of Antimicrobial ChemoTherapy 44(3): 397-401
Rudramurthy, S.M.; Jatana, M.; Singh, R.; Chakrabarti, A. 2013: In vitro antifungal activity of Indian liposomal amphotericin B against clinical isolates of emerging species of yeast and moulds, and its comparison with amphotericin B deoxycholate, voriconazole, itraconazole and fluconazole Mycoses 56(1): 39-46
Oakley, K.L.; Moore, C.B.; Denning, D.W. 1998: In-vitro activity of voriconazole against Aspergillus spp. and comparison with itraconazole and amphotericin B Journal of Antimicrobial ChemoTherapy 42(1): 91-94
Oakley, K.L.; Moore, C.B.; Denning, D.W. 1997: In vitro activity of Sch-56592 and comparison with activities of amphotericin B and itraconazole against Aspergillus spp Antimicrobial Agents and Chemotherapy 41(5): 1124-1126
Oakley, K.L.; Moore, C.B.; Denning, D.W. 1997: In vitro activity of SCH-56592 and comparison with activities of amphotericin B and itraconazole against Aspergillus spp Antimicrobial Agents and ChemoTherapy 41(5): 1124-1126
Martín-Mazuelos, E.; Pemán, J.; Valverde, A.; Chaves, M.ón.; Serrano, M.C.; Cantón, E. 2003: Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp Journal of Antimicrobial ChemoTherapy 52(3): 365-370
Moore, C.B.; Walls, C.M.; Denning, D.W. 2000: In vitro activity of the new triazole BMS-207147 against Aspergillus species in comparison with itraconazole and amphotericin B Antimicrobial Agents and ChemoTherapy 44(2): 441-443
Cuenca-Estrella, M.; Rodríguez-Tudela, J.L.; Mellado, E.; Martínez-Suárez, J.V.; Monzón, A. 1998: Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus Journal of Antimicrobial ChemoTherapy 42(4): 531-533
Venkateswarlu, K.; Denning, D.W.; Kelly, S.L. 1997: In-vitro activity of D0870, a new triazole antifungal drug, in comparison with fluconazole and itraconazole against Aspergillus fumigatus and Candida krusei Journal of Antimicrobial ChemoTherapy 39(6): 731-736
Ramani, R.; Gangwar, M.; Chaturvedi, V. 2003: Flow cytometry antifungal susceptibility testing of Aspergillus fumigatus and comparison of mode of action of voriconazole vis-à-vis amphotericin B and itraconazole Antimicrobial Agents and Chemotherapy 47(11): 3627-3629
Connolly, P.; Wheat, J.; Schnizlein-Bick, C.; Durkin, M.; Kohler, S.; Smedema, M.; Goldberg, J.; Brizendine, E.; Loebenberg, D. 1999: Comparison of a New Triazole Antifungal Agent, Schering 56592, with Itraconazole and Amphotericin B for Treatment of Histoplasmosis in Immunocompetent Mice Antimicrobial Agents and Chemotherapy 43(2): 322-328
Connolly, P.; Wheat, J.; Schnizlein-Bick, C.; Durkin, M.; Kohler, S.; Smedema, M.; Goldberg, J.; Brizendine, E.; Loebenberg, D. 1999: Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice Antimicrobial Agents and ChemoTherapy 43(2): 322-328
Moore, C.B.; Walls, C.M.; Denning, D.W. 2001: In vitro activities of terbinafine against Aspergillus species in comparison with those of itraconazole and amphotericin B Antimicrobial Agents and ChemoTherapy 45(6): 1882-1885
Denning, D.W.; Hanson, L.H.; Stevens, D.A. 1990: In vitro activity of saperconazole (R66 905) compared with amphotericin B and itraconazole against Aspergillus species European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 9(9): 693-697